[1]Patent:WO2016/54315,2016,A1.Locationinpatent:Page/Pagecolumn68;69
[2]Patent:WO2019/108797,2019,A1.Locationinpatent:Paragraph0118
[3]InternationalJournalofMolecularSciences,2017,vol.18
[4]Patent:CN107789630,2018,A.Locationinpatent:Paragraph0085;0086;0087
[5]Patent:CN108743968,2018,A.Locationinpatent:Paragraph0028;0029;0030
[6]Patent:WO2015/106599,2015,A1.Locationinpatent:Paragraph133
[7]Patent:WO2017/25057,2017,A1.Locationinpatent:Paragraph0140-0141
[8]Patent:CN109200291,2019,A.Locationinpatent:Paragraph0051;0071;0072;0073
Title: Okeley, et al. Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate. Clinical Cancer Research (2010), 16(3), 888-897.
Title: Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.
Title: Jianmin Fang, et al. Anti-her2 antibody and conjugate thereof. US 20160304621 A1.